EasyNAT MTC Assay
Ongoing Challanges
- There were 10.6 million new TB cases globally (133/100,000 incidence), causing 1.3 million deaths (twice the number of HIV/AIDS fatalities).
- 6.2 million pulmonary TB cases were diagnosed, but 37% lacked bacteriological confirmation.
- The WHO’s End TB Strategy emphasizes early and accurate laboratory diagnosis to curb the epidemic.
Product Overview
This assay is an automated, in vitro nucleic acid amplification test for the qualitative detection of “M. tuberculosis” Complex (MTC) DNA in sputum samples from individuals suspected of having TB infection.
Result in less than 60 minutes
Accurate LOD: 100 CFU/mL
Optimized three-step process with an integrated system
Clinical Value
Significantly improves preliminary screening of suspected TB cases.
Provides early and accurate results to accelerate the treatment process.
A cost-effective solution benefiting pulmonary TB patients
Product Resources
EasyNAT® MTC Assay
Brochure
EasyNAT® MTC Assay
Instructions for Use
EasyNAT® MTC Assay
SOP
